or Try an Advanced Search...

    Technical Analysis for SNGX - Soligenix, Inc.

    Grade Last Price % Change Price Change
    F 0.39 5.90% 0.02
    SNGX closed down 6.77 percent on Wednesday, May 15, 2024, on 15 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SNGX trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 5.91%
    Expansion Breakdown Bearish Swing Setup 5.91%
    Bollinger Band Squeeze Range Contraction 5.91%
    New 52 Week Low Weakness 5.91%
    Stochastic Reached Oversold Weakness 5.91%
    BB Squeeze + Lower Band Touch Range Contraction 5.91%
    BB Squeeze Started Range Contraction 5.91%
    Below Lower BB Weakness 5.91%
    Down 3 Days in a Row Weakness 5.91%
    Down 4 Days in a Row Weakness 5.91%
    Older End-of-Day Signals for SNGX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 2 hours ago
    Up 5% about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SNGX Chart by TradingView
    Basic chart:

    Profile

    Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ' (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Treatment Gastrointestinal Radiation Therapeutic Products Toxins Proteins Biodefense Biological Warfare Gastrointestinal Disease Lectins Biotherapeutic Products

    Is SNGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 6 Soligenix to Present at Upcoming Conferences
    Apr 25 Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
    Apr 18 Soligenix stock dips on pricing $4.75 million securities offering
    Apr 18 Soligenix Announces Pricing of $4.75 Million Public Offering
    Apr 15 Why Is Penny Stock Soligenix Trading Higher On Monday?
    Apr 15 FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
    Apr 11 SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™…
    Apr 11 FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
    Apr 9 Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Apr 3 Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency
    See more SNGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.0
    52 Week Low 0.3609
    Average Volume 3,317,916
    200-Day Moving Average 0.57
    50-Day Moving Average 0.51
    20-Day Moving Average 0.40
    10-Day Moving Average 0.40
    Average True Range 0.04
    RSI (14) 32.89
    ADX 25.96
    +DI 22.09
    -DI 20.39
    Chandelier Exit (Long, 3 ATRs) 0.48
    Chandelier Exit (Short, 3 ATRs) 0.49
    Upper Bollinger Bands 0.44
    Lower Bollinger Band 0.37
    Percent B (%b) -0.12
    BandWidth 16.20
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0043
    Fundamentals Value
    Market Cap 3.83 Million
    Num Shares 10.5 Million
    EPS -1.46
    Price-to-Earnings (P/E) Ratio -0.25
    Price-to-Sales 7.44
    Price-to-Book 1.65
    PEG Ratio -1.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.42
    Resistance 3 (R3) 0.43 0.41 0.41
    Resistance 2 (R2) 0.41 0.40 0.41 0.41
    Resistance 1 (R1) 0.39 0.39 0.38 0.38 0.40
    Pivot Point 0.37 0.37 0.37 0.37 0.37
    Support 1 (S1) 0.35 0.36 0.34 0.34 0.32
    Support 2 (S2) 0.34 0.35 0.33 0.32
    Support 3 (S3) 0.31 0.34 0.32
    Support 4 (S4) 0.31